Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Oxoid Announces Infection Control Awards

By HospiMedica staff writers
Posted on 05 May 2005
The first prize in the 2004/2005 Oxoid Infection Control Team of the Year Awards was won by Kingston Hospital NHS (National Hospital Service) Trust (Kingston-on-Thames, UK). More...


In awarding the first prize of U.S.$9,500, the judges commented that this small infection control team showed numerous examples of good practice that could be emulated by others and had a proactive and practical approach. Its successes included reduced infection rates in orthopedic surgery, implementation of Creutzfeldt-Jakob disease guidance, instigation of an intravenous implementation group to look at improving practices, and hand hygiene audits that have led to raised compliance. The team members' commitment to education and the sharing of knowledge has also produced results, as they held infection-control conferences that have been attended by other hospitals, general practitioners, and healthcare workers.

The second prize of $1,900 went to Sanatorio Adventista del Plata (Entre Rios, Argentina). With very limited resources and support, this infection control team has demonstrated significant improvements in infection prevention and control. The team has taught patients, clinical staff, and visitors about infection prevention and control procedures, written infection-control manuals, and has substantially reduced the rates of nosocomial infection in intensive care units (ICUs) and surgical sites.

The third prize of $950 went to a team at Doncaster and Bassetlaw Hospitals (Doncaster, UK), whose main challenge is to provide an integrated service across widely spaced locations up to 20 miles apart. The team demonstrated a coordinated approach to microbiologic procedures within the laboratories at Doncaster Royal Infirmary and collaborated with the antibiotic pharmacist and surgeons to produce a unified prescribing policy in orthopedic surgery, with resulting savings and reduced antibiotic selection pressure.

Oxoid (Basingstoke, UK) makes these awards every year. To register for information on how to enter, e-mail Val Kane (val.kane@oxoid.com).




Related Links:
Oxoid

New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.